The renin-angiotensin system (RAS) is central to the control of blood pressure and fluid-electrolyte homeo stasis. A key feature of this enzymatic cascade is the tightly regulated secretion of renin by juxtaglomerular cells. Juxtaglomerular cells are able to sense and respond precisely to changes in blood pressure or extracellular fluid volume. They do so in part by communicating with adjacent cells at the juxtaglomerular apparatus, the circula tion and the sympathetic nervous system. Under normal conditions, secretion of renin by juxtaglomerular cells is sufficient to maintain blood pressure and fluid homeo stasis. However, juxtaglomerular cells are not the only cells that can produce renin (FIG. 1a) . In the kidney, a sub set of mesangial cells, arteriolar smooth muscle cells, interstitial pericytes and tubular cells also produce renin and serve in a local or systemic capacity to ensure blood pressure and fluid-electrolyte homeo stasis. Beyond the kidney, renin precursor cells have been identi fied in multiple embryonic and postnatal tissues. The role of these precursors and their descendant cells in organs and tissues that are not traditionally associated with blood pressure regulation is intriguing, but data suggest that these cells have equally important functions in regener ation and immune defence mechanisms. Furthermore, an increasing body of evidence indicates that renin expressing cells and their descendants are not terminally differentiated as originally thought. Rather, these cells demonstrate plasticity and are involved in a multiplic ity of functions such as nephrovascular development and the regeneration of injured glomeruli. In addition, reninexpressing cells are linked to other fundamental homeostatic systems such as the control of red blood cells and oxygen supply to tissues, haematopoiesis and immune responses. In aggregate, reninexpressing cells seem to have acquired multiple functions designed to defend the organism against a variety of homeostatic challenges (FIG. 1b) . Here, we review some of the key pro cesses by which reninexpressing cells sustain homeo stasis of various systems during development and in response to physiological or pathological threats.
Renin-expressing cells in development
In mice, cells that express renin are first observed around embryonic day 8.5 (E8.5), before the morpho genesis of most organs has been initiated
Juxtaglomerular cells
A specialized group of renin-producing, myo-epithelioid, granulated cells located at the tip of the afferent arterioles at the entrance to the glomeruli.
Juxtaglomerular apparatus
The functional sensory and responding unit of the reninangiotensin system; it is composed of the afferent and efferent arterioles, the macula densa and the extraglomerular mesangium.
Renin cells in homeostasis, regeneration and immune defence mechanisms
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Abstract | An accumulating body of evidence suggests that renin-expressing cells have developed throughout evolution as a mechanism to preserve blood pressure and fluid volume homeostasis as well as to counteract a number of homeostatic and immunological threats. In the developing embryo, renin precursor cells emerge in multiple tissues, where they differentiate into a variety of cell types. The function of those precursors and their progeny is beginning to be unravelled. In the developing kidney, renin-expressing cells control the morphogenesis and branching of the renal arterial tree. The cells do not seem to fully differentiate but instead retain a degree of developmental plasticity or molecular memory, which enables them to regenerate injured glomeruli or to alter their phenotype to control blood pressure and fluid-electrolyte homeostasis. In haematopoietic tissues, renin-expressing cells might regulate bone marrow differentiation and participate in a circulating leukocyte renin-angiotensin system, which acts as a defence mechanism against infections or tissue injury. Furthermore, renin-expressing cells have an intricate lineage and functional relationship with erythropoietin-producing cells and are therefore central to two endocrine systems -the renin-angiotensin and erythropoietin systems -that sustain life by controlling fluid volume and composition, perfusion pressure and oxygen delivery to tissues. However, loss of the homeostatic control of these systems following dysregulation of renin-expressing cells can be detrimental, with serious pathological events.
Plasticity
The ability of cells to switch phenotypes.
Metanephros
The definitive kidney of adult mammals.
Fetal zone
A large, eosinophilic steroidogenic group of cells of the fetal adrenal gland, which is believed to involute after birth.
Mural cells
Cells located within the wall(s) of the renal arterioles, including smooth muscle cells and renin-expressing cells such as juxtaglomerular cells. In larger arteries, adventitial cells such as fibroblasts and perivascular pericytes are sometimes considered mural cells. Although part of the arterial wall, endothelial cells are not usually considered mural cells.
Stromal compartment
One of the three main compartments of the developing kidney; it contains FOXD1 + progenitors of vascular smooth muscle cells, renin-expressing cells, mesangial cells and pericytes as well as SCL + progenitors of endothelial cells of arteries and arterioles, glomeruli and interstitial capillaries.
Vasculogenesis
De novo, local differentiation and assembly of blood vessels from resident progenitor cells that are usually derived from multiple clones.
variety of other tissues 3 (FIG. 1a) . Before reninexpressing cells are observed in the developing metanephros, they can be seen distributed throughout the fetal adrenal glands, including within their transient fetal zone 3 . The adult adrenal gland is composed of cells from different embryonic sites, and lineage tracing of reninexpressing cells in the adult adrenal gland reveals radial stripes of labelled cells (derived from reninexpressing cells) run ning throughout the adrenal cortex as well as groups of labelled cells within the adrenal medulla. Interestingly, and as discussed in detail below, cells of the renin lin eage that are present in the adult adrenal cortex possess the plasticity to reexpress renin when aldosterone is blocked by deletion of aldosterone synthase or when the main source of circulating renin is removed (by bilateral nephrectomy). Such plasticity, which is also evident in cells that line the renal arterioles, is discussed in more detail below [4] [5] [6] . The appearance of reninexpressing cells in the metanephric kidney is a relatively late event in the developmental history of these cells, occurring at around E11-12 (REF. 7 ).
The wide distribution of reninexpressing cells throughout development poses a series of questions that have remained for the most part unanswered. For instance, we do not currently know whether the transient or permanent expression of renin marks a special group of cells with specialized functions, and if so, the function of those cells. Current evidence, as discussed below, suggests that cells derived from renin progenitors maintain a degree of plasticity, but whether reninexpressing cells provide a reservoir of progenitor cells is also unknown 7 . Available evidence also suggests that reninexpressing cells have a role in the growth and differentiation of the tissues they populate during embryonic development 2, 8 ; however, the exact role of these cells in these processes requires further investi gation. Insights into the transcriptional machinery of reninexpressing cells in different organs and tissues (for example, in bone marrow and kidney) might shed light on the nature and evolution of these cells, as discussed below 9 .
Vascular progenitors
In the developing mammalian kidney, precursors for the mural cells of the kidney arterioles emerge well before arterial vessels can be discerned by histological means 8 . These precursors are distributed within a loose and hetero geneous group of cells that constitute the stromal compartment 10 (FIG. 2) . Within the stromal compartment, forkhead box protein D1 (FOXD1)expressing cells give rise to reninexpressing cells -including the juxta glomerular cells -as well as vascular smooth muscle cells, mesangial cells, interstitial pericytes and interstitial fibroblasts 10,11 (FIG. 1a) . By contrast, cells in the stromal compartment that express stem cell protein (SCL; also known as TAL1) give rise to endothelial cells of the arte rioles, glomeruli and peritubular capillaries 12 . Following transplantation of murine embryonic kidneys at a stage (E11) in which they are devoid of any arterial blood ves sels into the anterior chamber of the eye or under the renal capsule of an adult host mouse, the transplanted embryonic kidneys undergo not only nephrogenesis but also vascular development that resembles the arterial and arteriolar developmental pattern observed in vivo 8 . In fact, the mural cells, including reninexpressing cells, differentiate appropriately, distribute within expected sites along the renal arteriolar tree and connect to vas cularized glomeruli, suggesting that stromal precursors have the capacity to assemble and form the kidney arte rioles in situ 8, 10 . These experiments demonstrated the contribution of precursors from the adult host tissue to be nonexistent, indicating that the blood vessels prob ably originated from the transplanted embryonic tissue through an initial process of vasculogenesis followed by angiogenesis 8 . Transplantation of an embryonic kidney under the kidney capsule of a newborn host, however, induces the development of blood vessels from both the transplanted organ and the host 13 , suggesting that pro genitors from outside the kidney participate in blood vessel formation. Although the contribution of extra renal progenitors to renal vascular development requires further study, in both of the experimental conditions described above the host kidney provided the trans planted embryonic kidneys with the appropriate differ entiation signals and positional information to direct reninexpressing cells and other vascular cells to their appropriate locations along the renal arterial tree 8, 13 . The identification of these signals would represent a major step forward in understanding the mechanisms of kid ney vascular development and has potential to aid in the generation of vascularized organs in vitro.
Renin cells in vascular development
As mentioned above, renin precursor cells in the devel oping metanephric kidney arise from FOXD1expressing cells 11, 14 (FIGS 1a,2). The development of the renal arterial tree and the location of reninexpressing cells throughout this process follow an iterative, fractallike pattern (FIG. 3) . In early stages (E11-12), only a few renin expressing cells are present and are randomly distributed in the stromalinterstitial compartment. As development progresses, the reninexpressing cells actively participate in the morpho genesis and branching of the renal arterial tree 15 . As a
Key points
• Renin-expressing cells are evolutionarily conserved and have retained features to contribute to the defence against threats to survival such as bleeding, dehydration, hypotension and/or hypoxia • In the embryo, renin-expressing cells populate diverse tissues where they might have a role in tissue morphogenesis and growth; in the developing kidney, they are progenitors for arteriolar and mesangial cells and are crucial for arteriolar branching morphogenesis • In adults, cells derived from progenitors that previously expressed renin retain their developmental memory and can regenerate injured glomeruli or re-express renin to achieve blood pressure and fluid-electrolyte homeostasis • Renin-expressing cells are linked to other fundamental homeostatic systems, such as the haematopoietic and circulating leukocyte renin-angiotensin systems, through which they might contribute to bone marrow development and the local control of inflammation or infections • Renin-expressing cells intersect with erythropoietin-producing cells and are therefore at the crossroads of two key life-sustaining systems involved in the control of fluid volume, perfusion pressure and oxygen delivery to tissues
Angiogenesis
The formation of new blood vessels, usually by sprouting of new branches from pre-existing vessels. This process usually involves the proliferation and/or elongation of cells from single clones. In the case of arterioles, it is followed by the recruitment of perivascular smooth muscle cells.
Fractal
A shape or structure made of smaller parts or units that repeat themselves and resemble the whole.
new branch begins to form, a group of cells coalesces and forms a bulge, which elongates and matures into a new arteriolar branch 15 . As the renin expressing cells mature and the vessel is consolidated, the reninexpressing cells differentiate into vascular smooth muscle cells. This pro cess is repeated numerous times over a period of several weeks until maturation and elongation of the arterial tree is complete soon after birth 2 . Reninexpressing cells are therefore extensively and heterogeneously distributed throughout the embryonic kidney, and this distribu tion pattern changes continuously until maturation of the arterial tree is complete [16] [17] [18] . As the vessels mature and the cells differentiate into smooth muscle cells, reninexpressing cells are progressively restricted to the juxtaglomerular apparatus, where they remain through out adult life 19 . The factors and mechanisms that control this developmental restriction are not well understood but are most likely associated with the mechanisms that control the differentiation of cells into smooth muscle and mesangial cells, including cAMP, FOXD1 and the Notch/recombining binding protein suppressor of hair less (RBPJ) signalling pathways. This changing pattern of renin distribution is conserved across species and has been demonstrated in every mammal examined, includ ing rats, mice, pigs, sheep and humans 7, [20] [21] [22] [23] . Interestingly, the ontogeny of renin distribution during mammalian development replicates the phylogenetic pattern of renin distribution in adult animals, from large arteries in fish to the classic localization of juxtaglomerular cells in mam mals [24] [25] [26] [27] . As discussed below, the functions of renin in early development are thought to relate more to tissue morphogenesis than to regulation of arterial blood pres sure and fluid-electrolyte homeostasis -functions that become extremely important in extrauterine life 2, 24, 26, 27 . Regulation of renin-expressing cells in vascular development. As mentioned above, the major factors that control the differentiation and maintenance of renin expressing juxtaglomerular cells include several compo nents of the cAMP pathway [28] [29] [30] [31] [32] , the transcription factor FOXD1 and the Notch/RBPJ pathway 11, 14, 33 . The second messenger cAMP is a wellknown regu lator of renin synthesis and release 31, [34] [35] [36] [37] . Under normal physiologic circumstances, membranebound βadrenergic receptors located in juxtaglomerular cells control the expression and release of renin via the generation of intracellular cAMP. Stimulation of mem branebound βadrenergic receptors results in activation of stimulatory G protein subunit α (G s α) and adenyl cyclase, resulting in the generation of intracellular cAMP and activation of protein kinase A followed by phos phorylation of the transcription factor CREB (cAMP responsive elementbinding protein). In turn, CREB binds the cAMPresponsive element (CRE) located within the 5ʹ regulatory regions of the renin gene (REN). The most prominent CRE is located within the renin enhancer. Access to CRE and binding of CREB is enabled by the histone acetyl transferases CREBbinding protein (CBP) and p300, which deposit acetyl marks in histones around the CRE, resulting in the local relaxation of chro matin and displacement of nucleosomes and providing access for CREB, which elicits transcription of REN. cAMP also activates other genes characteristic of the renin phenotype, including Akr1b7
38
-encoding aldose reductaserelated protein 1 (AKR1B7), which is highly expressed in reninexpressing cells during development and in the adult. AKR1B7 is believed to be a detoxifying enzyme that is capable of transforming harmful alde hydes into alcohols. Expression of AKR1B7 can be used as an independent marker of reninexpressing cells, even when REN has been deleted 38, 39 . Gene deletion studies have demonstrated that most of the components of the cAMP pathway are crucially involved in the differentiation and/or maintenance of reninexpressing cells. Conditional deletion of G s α, which is coupled to membranebound βadrenergic receptors in renin cell precursors leads to a marked decrease in the number of reninexpressing cells in the vascula ture accompanied by arteriolar abnormalities in early life 29, 32, 40 . Furthermore, homozygous conditional dele tion of both CBP and p300 results in an absence of renin expressing cells in the adult and severe nephro vascular abnormalities 30, 31 . These results clearly demonstrate the importance of the cAMP pathway in the development of renin expressing cells and the central role of this pathway in the maintenance of kidney vascular integrity.
The Notch/RBPJ pathway is an evolutionary con served celltocell communication system involved in cell fate decisions during development 41, 42 . Renin expressing cells possess Notch receptors, Notch lig ands and the Notch transcriptional effector RBPJ 39 . Deletion of RBP-J in reninexpressing cells reduced the number of reninexpressing cells and induced a remarkable change in the identity of the cells, charac terized by an impaired ability to generate smooth muscle proteins and loss of their characteristic plump granular myoepithelioid appearance, becoming thin, devoid of granules and poorly responsive to stimuli that activate renin expression 33, 43 (FIG. 4) . However, deletion of RBP-J in more primitive FOXD1
+ renin precursor cells not only reduced the number of reninexpressing cells but also resulted in thinner blood vessels and glomeruli that were devoid of mesangial cells with consequent development of glomerular aneurysms 14 . These studies indicate that the Notch/RBPJ pathway is crucial for the development of reninexpressing cells as well as for the appropriate differentiation of kidney arterioles and mesangial cells. The studies also indicate that loss of Notch activity in early precursors leads to a more severe phenotype than does deletion in more differentiated cells.
Further evidence of a fundamental role for the renal stromal compartment in the development of the kid ney vasculature and the differentiation of renin cells is provided by ablation studies of FOXD1 + cells. Ablation of FOXD1 + cells with diphtheria toxin and global dele tion of FOXD1 induced the development of aberrant arterioles that penetrated the kidneys from abnormally developed subcapsular arteries 11 . In addition, deletion of FOXD1 or elimination of FOXD1 + cells led to a signifi cant reduction in the number of reninexpressing cells, suggesting that the transcription factor FOXD1 governs a molecular programme that controls the origin, num ber and orientation of the renal arterioles and the cel lular endowment of the renal arterial tree 11 . Given the complexity of these processes and their potential effects on ureteric and nephron development, further studies are required to determine how FOXD1 controls guid ance cues, cell number and the fate of the nephron and its vasculature.
The prorenin receptor. The prorenin receptor (PRR; also known as ATP6AP2) is another renininteracting factor that is known to be involved in kidney develop ment and may control the development of the kidney vasculature and differentiation of reninexpressing cells [44] [45] [46] [47] . The presence of this receptor was anticipated several decades ago 48, 49 and was subsequently confirmed using expression cloning 50 . The PRR binds both renin and prorenin: binding of prorenin generates active renin whereas binding of renin amplifies the hydrolysis of angiotensinogen to angiotensin I. However, the PRR has very low affinity for prorenin and it is unlikely that the levels of prorenin required to activate the receptor can be achieved in vivo 45 . Interestingly, nonrenin binding partners seem to be responsible for the striking and important effects of the PRR [44] [45] [46] [47] . For example, the PRR is an accessory subunit of the vesicular VATPase and colocalizes in the plasma membrane with the Wnt receptor Frizzled (Fz) and lowdensity lipoprotein receptor related protein 6 (LRP6). These proteins are essential for lysosomal functions such as endocytosis and autophagy, for various developmental processes and for cell proliferation and differentiation.
Global deletion of PRR is embryonically lethal, indicating its important role in development 44, 45 . The PRR is widely expressed in the developing kidney in the glomerular, tubular and vascular compartments 44 . Conditional deletion of PRR in cell types derived from homeobox protein HoxB7 (HOXB7)expressing cells, such as collecting duct cells (FIG. 1a) , results in kidney hypoplasia and a decreased ability to concentrate and acidify the urine 44 . As expected, deletion of PRR in podo cytes results in massive proteinuria and kidney failure 51 . Deletion of PRR in homeobox protein SIX2 (SIX2) expressing nephron progenitor cells results in small cystic kidneys and reduced nephron numbers 52 . The PRR is also present in the kidney vasculature 44 ; however, its role in the development of arteriolar smooth muscle and reninexpressing cells has not been ascertained. Given the important role of PRR in developmental pro cesses, it is very likely that the PRR is involved in the differentiation of both cell types.
Blood pressure and volume homeostasis
Anatomical and functional studies indicate that juxta glomerular cells are sensors of the renal and extrarenal environment: they interpret and respond to signals that convey the level of perfusion pressure and the status of the extracellular fluid volume 37 . Three major physio logical mechanisms control renin synthesis and release: the concentration of sodium chloride (NaCl) in the Nature Reviews | Nephrology 
Developmental memory
The ability of cells to expressly re-acquire a phenotype previously expressed during development.
Metaplastic transformation
Pathological transformation of one cell type into another not related by lineage.
macula densa, whereby a decrease in NaCl concentra tion stimulates renin synthesis and release; perfusion pressure as sensed by renal baroreceptors, whereby a decrease in perfusion pressure stimulates renin release; and βadrenergic receptor activity, whereby activation of βadrenergic receptors in juxtaglomerular cells by circu lating or locally released catecholamines stimulates renin release. Usually, these mechanisms are activated simul taneously to finetune the appropriate amounts of renin released to the circulation 37 (FIG. 5) . In addition, angio tensin II (ANGII) exerts a negative feedback inhibition on renin release; however, whether this effect is due to a direct effect of ANGII on type 1 ANGII receptors present in juxtaglomerular cells or is secondary owing to an increase in blood pressure is not entirely clear [53] [54] [55] . In unstressed adults, secretion of renin by the few exist ent juxtaglomerular cells is usually sufficient to main tain a homeostatic balance of blood pressure and fluid homeostasis 7 . However, under more strenuous and per sistent challenges such as chronic dehydration, persistent hypotension and/or chronic inhibition of the RAS, juxta glomerular cells are maximally stimulated, after which additional cells along the afferent arterioles, interstitium and glomeruli (likely smooth muscle cells, interstitial peritubular pericytes and mesangial cells) are stimu lated to produce renin until the crisis passes and homeo stasis is reestablished 3,7,56-64 . Thus, under strenuous circumstances, maintenance of volume and pressure homeostasis depends largely on the number of cells that can produce and release renin 34, 60, 63 . Interestingly, proximal and connecting tubule epithelial cells can also reexpress renin under certain conditions [65] [66] [67] [68] .
Mechanisms to increase renin cells
Several processes have been proposed to be responsible for the increased number of reninexpressing cells under states of physiological stress related to blood pressure and volume imbalance (FIG. 6) .
Developmental memory. The most prominent mech anism involves the renewed production of renin expres sion by cells that are descendants of renin progenitor cells and were therefore capable of producing renin during development 3, 16, 19, 43, 63, 69 . For example, arteriolar smooth muscle cells, mesangial cells and interstitial pericytes retain the plasticity and developmental memory to express renin when confronted with a homeostatic challenge -a process that should not be confused with metaplastic transformation 56 . Estimates suggest that in the kidney this process accounts for about 90% of the increase in the number of reninproducing cells follow ing a relevant physiologic challenge 3 , suggesting that preservation of the developmental memory of the renin phenotype is a fundamental builtin mechanism to deal Nature Reviews | Nephrology By contrast, deletion of RBP-J in RPCs leads to a change in their fate, as they are no longer able to synthesize renin and properly express smooth muscle genes. Despite the low blood pressure of these mice, the mutant cells are unable to reactivate renin expression. In addition, they do not reactivate renin expression in response to a challenge such as sodium depletion combined with angiotensin-converting enzyme inhibition. E, embryonic day; P, postnatal day; RBP-J, recombining binding protein suppressor of hairless.
Hyperplasia
Increase in cell number, usually due to increased cell proliferation.
Neogenesis
De novo expression of a gene (for example, renin) in a cell that has not previously expressed the gene.
with homeostatic threats. It remains unclear whether the increased renin production involves some degree of cell proliferation; therefore, we suggest that the term juxtaglomerular cell hyperplasia be avoided until more convincing evidence is obtained 70, 71 . We expect that reactivation of renin expression by nonreninproducing cells uses an established develop mental programme whereby an epigenetic imprint that affects the spatial organization of the chromatin struc ture of the renin phenotype is left in the genome as the cells differentiate into smooth muscle or mesangial cells. The retransformation of these cells under conditions of stress has been extensively documented in animals, but it can also be transiently observed in vitro through the use of cells derived from the progeny of reninexpressing cells 7, 31, 34, 63 . This finding suggests that reacquisition of the renin phenotype is a cell autonomous process whereby each individual cell conserves its developmental mem ory and ability to respond to the appropriate stimuli with renin secretion 1, 69 . The ability of cells to reacquire a reninexpressing phenotype might not be limited to kidney cells. As mentioned above, cells in the develop ing fetal adrenal gland express renin earlier and more abundantly than in the embryonic metanephros. Studies from the early 1980s showed that bilateral nephrec tomy with concomitant removal of the submandibular glands induced expression of renin in the adrenal cor tex of adult mice, indicating that these cells also retain developmental memory 6 . Furthermore, adult animals harbouring a null mutation in ALDOS, which encodes aldosterone synthase, have reninexpressing cells -not only along the kidney arterioles but also in the adrenal gland -suggesting that the adult adrenal gland retains a group of cells that are capable of regaining the renin phenotype under stressful conditions 5 . Two major signalling systems, the cAMP/CBP/p300 pathway and the evolutionary conserved Notch/RBPJ celltocell communication system, are crucial in sup porting the identity of reninexpressing cells and the ability of smooth muscle cells to reexpress renin 1, 43 . How these two pathways are coordinated with one another remains to be defined. In addition to the cAMP and Notch pathways, other factors modulate the identity of reninexpressing cells, including, but not limited to, microRNAs, connexins and cell-matrix interactions 30, 31, [72] [73] [74] [75] .
Neogenesis. Another mechanism, termed 'neogenesis' (FIG. 6) has been demonstrated to contribute to the pool of reninexpressing cells 76 . By using double transgenic mice 77 , in which all cells that ever expressed renin are labelled with cellmembranelocalized enhanced green fluorescent protein (mG) fluorescence whereas cells that never expressed renin were labelled with cell membrane localized tdTomato (mT) fluorescence, the investigators could visualize cells that were activating REN for the first time and were therefore expressing mG fluorescence while temporarily retaining mT fluorescence. Thus, for a short period of time, the new renin expressing cells were dually positive for mT and mG. In this con text, 'neogenesis' means de novo expression of renin in a cell that has never expressed renin. The researchers found that neogenesis not only occurs during develop ment, as expected, but also persists in adulthood and can be stimulated by pharmacological treatment with the angiotensin converting enzyme (ACE) inhibitor, captopril, and by mesangial cell injury 76 and that this process contributes about 10% of the total number of reninexpressing cells. This mechanism could serve to maintain the pool of reninexpressing cells under normal homeostatic conditions as well as serve as a mechanism to respond to a sustained demand for renin under pathophysio logical circumstances. Whether these Nature Reviews | Nephrology A decrease in sodium chloride (NaCl) concentration at the macula densa stimulates renin synthesis and release. Activation of β-adrenergic receptors (β-ARs) present in juxtaglomerular cells induces renin synthesis and release via the cAMP pathway (inset). Generation of cAMP leads to activation of protein kinase A (PKA) and phosphorylation of CREB (cAMP-responsive element-binding protein), a transcription factor that binds CRE (cAMP-responsive element) and activates renin transcription. Angiotensin II inhibits renin synthesis and release (through a negative feedback loop) via activation of the type-1 angiotensin II receptor (AT1R; also known as AGTR1) and by increasing blood pressure. AC, adenyl cyclase; CBP, CREB-binding protein; G s α, stimulatory G protein subunit α.
Direct transdifferentiation
Transformation of one cell into another without reprogramming into induced pluripotent stem cells.
neogenic cells came from a pool of FOXD1 + progenitor cells that have not yet expressed renin or from other mes enchymal cells is currently unknown. Also unknown is whether these new reninsynthesizing cells arise through direct transdifferentiation of lineageunrelated adult cells that are already committed to a nonrenin phenotype. These exciting possibilities remain to be investigated.
Prostaglandin-E 2 -mediated induction of mesenchymal stem-like cells. A third process that potentially contributes to the number of reninexpressing cells is through activation of a small fraction of CD44 + mes enchymal stemlike cells 78 . Under situations of sodium depletion, these cells are thought to be activated by the production of prostaglandin E 2 (PGE 2 ), which acts on the prostanoid EP4 receptors in those CD44 + cells to induce the migration of these cells to the juxtaglomer ular apparatus where they insert themselves among the existent pool of juxtaglomerular cells 79 . On arrival in the juxtaglomerular area, these cells stop produc ing CD44 and express renin 79 . Although PGE2-EP4 receptor interactions almost certainly have a role in renin synthesis and release, the specific participation and degree of contribution of mesenchymal stemlike cells to the pool of reninexpressing cells require further study. Of note, CD44 expression is not a true marker of mesenchymal stem cells but is usually observed as an artefact of culture conditions 80, 81 . Given that CD44 is also expressed by a variety of other cell types, includ ing macrophages, the nature of these renal CD44 cells remains to be defined.
Consequence of increased renin expression
Regardless of the mechanism involved, cells that are induced to express renin undergo a remarkable trans formation to an endocrine phenotype: the cells become plump and epithelioid; they acquire granules where renin is stored; their endoplasmic reticulum and Golgi apparatus become prominent; their glycogen content increases; and the number of myofibrils diminishes 20 . This remarkable cellular transformation is accomplished by the activation of a molecular-epigenetic programme involving the expression of genes characteristic of the renin phenotype, such as Akr1b7, which, as mentioned earlier, encodes an aldoketo reductase that is involved in the detoxification of harmful aldehydes produced during the high renin synthetic period of the cells 38, 39 . In addition, the transformed cells express miR330. The function of this microRNA is unclear, but it has been proposed to counteract the stimulatory effects of miR125p5b on the smooth muscle phenotype of reninexpressing cells: whereas miR330 inhibits the expression of the smooth muscle protein smoothelin, miR125p5b stimulates it 75 . The transformed cells also express proteins that are involved in granulopoiesis, secretion and contractility 39, 75 . Of note, the mechanism of regulating homeostatic systems by changing the number of hormoneproducing cells is not exclusive to reninsecreting cells: in a model of highoutput heart failure induced by aortocaval fistula, ventricular myocardial cells reexpress atrial Nature Reviews | Nephrology , pericytes and mesangial cells -retain the memory to re-express renin when challenged by a physiological stressor, such as hypotension, dehydration or sodium depletion -a phenomenon referred to as developmental memory. c | In addition, renin-expressing cells can be generated de novo from non-renin-lineage-derived cells, either by a process of transdifferentiation whereby an existing non-renin cell (SMC or other precursor) is induced to express renin (neogenesis) or by transformation (or differentiation) of a mesenchymal stem-like cell into a renin-producing cell, potentially through the actions of prostaglandin E 2 on the prostanoid EP4 receptors.
natriuretic peptide in a pattern that resembles its normal expression in the embryonic heart 82 . Similarly, numbers of pancreatic βcells, thyroid cells and erythropoietin (EPO)synthesizing cells are increased to cope with the demands for insulin, thyroid hormone and EPO, respectively [83] [84] [85] [86] . In all these circumstances, adult cells are able to reexpress a hormone expressed by that cell type during development in response to a homeostatic threat. Where in the genome this developmental mem ory resides, how it is constructed and how it is retained throughout cell division remain to be determined.
Renin-expressing cells and regeneration
The protective role of renin cells might not be limited to the control of circulatory and fluid homeostasis. Over the past few years, two independent groups have shown that renin cells might be directly involved in the repair and/or regeneration of glomerular tissue 76, [87] [88] [89] . In an experimental model of mesangial prolifera tive glomerulonephritis 87 , one study used a conditional inducible reporter to show that reninexpressing cells, presumably juxtaglomerular cells, contributed about twothirds of the repopulated glomerular mesangial cells following mesangiolysis. Upon acquisition of the new mesangial phenotype, the cells stopped making renin and expressed markers of mesangial cells, including α8 integrin and plateletderived growth factor recep tor B. Similar to the processes that occur during develop ment, it seems that in this situation the newly developed mesangial cells differentiated from reninexpressing cells that had retained their progenitor capabilities. Whether this process resulted from the reemergence of a pre established developmental programme or from another mechanism remains to be ascertained.
In another experimental model of antipodocyte cytotoxic antibodyinduced focal segmental glomeru lar sclerosis 89 , cells that previously expressed renin were found to repopulate injured podocytes and a fraction of parietal epithelial cells in the Bowman capsule. In this scenario, juxtaglomerular cells seemingly migrated and replaced the injured cells 88 . Upon reaching the glomer ulus, the cells stopped synthesizing renin and expressed podocyte markers, including synaptopodin, nephrin and Wilms tumour protein (WT1) 89 . This intriguing finding elicits key questions. Given that podocytes are derived from SIX2 + progenitors rather than FOXD1 + progeni tors, the findings suggest that adult juxtaglomerular cells are able to transdifferentiate into another, lineage unrelated adult cell. Such transdifferentiation would require considerable rearrangement of transcriptional programmes and chromatin architecture to suppress genes that control renin cell identity and activate an entirely new epigenetic and transcriptional programme to drive the expression of podocyte identity genes. On the other hand, epithelial cells from the Bowman cap sule and proximal tubules that are derived from SIX2 + progenitors do express renin during embryonic life and can express renin under physiological stress or patho logical conditions 20, 65 ; whether these epithelial cells and/or juxta glomerular cells have the capacity to replace podocytes remains to be determined.
The nature of the signal(s) that trigger juxta glomerular cells to migrate and transdifferentiate into podocytes or mesangial cells has not yet been identi fied. Furthermore, the precise mechanisms responsible for such marked cellular transformation remain to be defined. As this process has potential clinical applica tions for the replacement of damaged renal cell popu lations, one aspect that requires formal exploration is whether this repair process is a transient phenomenon or whether it is a clinically relevant process, resulting in sustained improvement in glomerular function.
Renin-expressing cells and oxygen sensing
Oxygen is essential for life. Thus, the net availability of oxygen as determined by the local balance between oxygen supply and consumption is crucial for main taining oxygen homeostasis at the cellular and organis mal levels. Although a certain degree of tissue hypoxia might be necessary for adaptation to high altitude and for tissue development and vascular growth, hypoxia can also have pathological roles in processes such as cancer and diabetes mellitus 90 . Although somewhat controversial, acute hypoxia is generally acknow ledged to stimulate renin synthesis and secretion 90, 91 . However, as renal denerv ation does not prevent renin release in response to hypoxia, the activation of renin expressing cells could be mediated by mechanisms involving circulating cate cholamine activation of the renal baroreceptor and/or the macula densa. In addi tion to producing renin, kidneys also produce EPO in response to hypoxia, which in turn stimulates the pro duction of red blood cells in the bone marrow 92 . The cells that produce EPO have been identified as a spe cialized group of interstitial pericytes located near capil laries in the kidney cortex 90, 92 . When oxygen availability to these cells is diminished owing to either reduced oxygen delivery or increased oxygen consumption, EPOproducing interstitial pericytes, normally held in reserve, are massively recruited to produce EPO. Depending on its severity, anaemic or hypoxic condi tions can increase circulating levels of EPO up to 1,000 times higher than normal 93, 94 . EPO is then rapidly deliv ered to the circulation. Interestingly, EPOproducing fibroblasts originate from the same FOXD1 + progenitor cells that give rise to renin precursors and other cells of the kidney vasculature. Interestingly, and as discussed earlier, interstitial pericytes in mice and humans can also produce renin under certain circumstances 62, 95, 96 . These findings indicate a possible functional, although unclear, relationship between EPOproducing cells and reninproducing cells. Furthermore, under nor mal circumstances, reninexpressing juxtaglomerular cells express hypoxiainducible factor 2α (HIF2α; also known as EPAS1), which regulates EPO production 39 . Therefore, the mechanisms for sensing and responding to oxygen and those involved in the regulation of vol ume and blood pressure homeostasis seem to converge on these unique cell types that are capable of producing both EPO and renin. How these two systems cooperate to preserve homeostasis in both systems is a matter of intense investigation. Interaction between renin and EPO systems As mentioned above, reninexpressing cells are plastic and can switch their phenotype in response to endo genous and/or exogenous signals during both devel opment and disease. A study of genes involved in the hypoxia response revealed an extreme example of this plasticity 97 , whereby conditional deletion of the von Hippel-Lindau disease tumour suppressor (VHL) gene resulted in an accumulation of HIF2α in cells derived from the renin precursor cells, including smooth mus cle cells along the arterioles, juxtaglomerular cells and mesangial cells in mice 97 . This dysregulation of HIF2α induced renin descendant cells to constitutively express EPO, which was readily secreted into the circulation where it stimulated erythropoiesis in the bone marrow, causing the mice to develop secondary erythrocytosis 97 with haemato crits ranging from 60 to 70% (normal range 47-49%). The presence of circulating EPO under these conditions was presumed to have originated from descendants of reninexpressing cells 97 ; however, because non renal organs, such as the liver, can produce EPO under hypoxic conditions, this hypothesis needs to be validated. Interestingly, concurrent deletion of HIF2α prevented the erythrocytosis phenotype, suggesting that the plastic response was driven by HIF2αinduced stimulation of EPO synthesis 98 . The mechanism(s) underlying the shift in juxtaglomerular cells from a renin expressing to an EPOexpressing phenotype also requires study, as it is unclear whether the suppression of renin in these cells is the result of a direct (cell autono mous) effect or an indirect systemic effect of circulating EPO. In this regard, exposure of mice with specific dele tion of VHL in reninexpressing cells to a lowsalt diet and the ACE inhibitor enalapril (two powerful stimuli for renin synthesis and release) resulted in a blunted renin response, with renin mRNA levels increased only to about onethird of those achieved in similarly treated control animals 97 . Conversely, renal expression of EPO mRNA increased 46fold in response to the physio logical challenge 97 . Both responses are interesting and somewhat unexpected. The reason(s) for the blunted renin response to the physiological challenge remains to be elucidated, but several possibilities -that are not mutually exclusive -are possible. Under normal cir cumstances, both the macula densa and the baroreceptor mechanisms are activated in response to a lowsodium diet and enalapril, potentiating the renin response. However, the normal blood pressure of Vhl −/−REN mice 97 might blunt this renin response. The presence of normal blood pressure eliminates a powerful stimulus for renin release, as activation of the baroreceptor mechanism will not occur or will be diminished, thereby dampening the effect of sodium depletion on renin synthesis and release. Furthermore, sodium reabsorption by proximal tubular cells requires oxygen consumption. By decreas ing sodium reabsorption, ACE inhibition can reduce oxygen consumption 99, 100 , thereby exposing both renin expressing cells and pericytes to abovenormal intersti tial O 2 concentrations and markedly diminishing both renin and EPO expression. The effect of oxygen exposure cannot, however, explain the mechanisms of heightened EPO activation observed in response to sodium deple tion and enalapril in these mice. Further work is needed to ascertain why EPOsecreting cells respond so well to a manipulation that is known to activate renin synth esis and release. A second unexplained issue is whether the suppression of renin in mice with renin cellspecific deletion of VHL is due to an as yet speculative intrinsic molecular crosstalk between the HΙF2a/VHL genes and REN or whether the suppression of renin is secondary to the systemic effects of EPO on the kidneys via increased blood pressure and increased sodium delivery to the macula densa, as described below 99, 100 . This considera tion is important given that a secondary effect of EPO on renin expression might imply that REN is in fact respon sive and operating normally but is simply constrained in the intensity of its response given the physiological status of the model (that is, normal blood pressure and blunted baroreceptor response in the presence of high circulating EPO levels). Alternatively, the fact that only the renin response is limited might indicate that the juxtaglomerular cells are not fully converted to an EPO phenotype and that they are expressing both hormones to a certain extent.
A clue to the issues posed above is provided by an excellent study of healthy human volunteers who were treated with recombinant human EPO (rhEPO) for 28 days 100 . Interestingly in these volunteers, proxi mal tubular reabsorption of sodium was significantly decreased in response to rhEPO, consequentially enhancing the load of NaCl delivered to the macula densa and subsequently suppressing renin and aldos terone secretion 100 , suggesting that one of the earliest responses to exogenous EPO exposure is a decrease in renin secretion mediated by signals from the mac ula densa 100 . Together, these data suggest that the RAS and the EPO-oxygensensing system interact through various mechanisms involving cell plasticity, direct communication and indirect communication mech anisms through circulatory effects to maintain perfusion pressure and oxygen delivery to tissues in response to bleeding or hypoxia (FIG. 7) .
Haematopoiesis and immunity
Numerous studies have documented the presence of components of the RAS in haematopoietic tissues, including the bone marrow, spleen and thymus, and in circulating leukocytes 9, 101, 102 .
B renin cells
As described above, deletion of Rbp-j in mice led to a severe decrease in the number of cells expressing renin at 4 months of age. Fate tracing experiments demonstrated that the decrease in number of reninpositive cells was not due to cell death but rather to a marked change in the phenotype of these cells: the cells could not express renin, smooth muscle proteins or AKR1B7 33, 43 . They were also unable to make renin granules and lost their ability to express REN in response to sodium depletion and captopril treatment. Physiologically, these changes were reflected by low circulating renin and decreased blood pressure 33, 43 and indicated that RBPJ controls a genetic programme that determines the endocrine contractile phenotype of the cells. In addition, at about 6-8 months of age these mice developed a highly pene trant form of preB cell leukemia 9 . This unexpected finding prompted an investigation of the responsible cell group within the bone marrow. Using a variety of approaches including fate tracing, phenotyping with flow cytometry and RNA sequencing, we found that a subset of preB lymphocytes in the bone marrow, spleen and circulation express renin 9 ; we termed this subset B renin cells to indicate that they are reninexpressing cells of a lymphocyte pedi gree. Interestingly, B renin cells in the bone marrow and spleen are proportionally at least ten times more prevalent than renin cells in the kidney and share remarkable similarities with renin cells from the kidney 9 . Both cell types are developmentally regu lated and they decrease in number with maturation. In the kidney, this diminution in the number of cells is associated with the differentiation of renin progeni tors into other cell types, including the smooth muscle cells of the renal arterioles and glomerular mesangial cells 1 . The decrease in number of B renin cells in the bone marrow and spleen is potentially coupled with lymphocyte maturation, as suggested by the develop ment of a preB cell leukaemia phenotype in mice with deletion of the cellfate determinant Rbp-j 
RAS components in circulating leukocytes
Of particular interest is the role of circulating haemato poietic cells that express components of the RAS 101, 103 . In addition to renin expression, circulating leukocytes, as well as several distinct leukocyte subtypes (such as monocytes, neutrophils and lymphocytes), express other components of the RAS, including angiotensinogen, ACE and angiotensin receptors [101] [102] [103] . Although the role of the RAS within leukocytes is a subject of continued study, current evidence suggests that RAS components expressed by white blood cells within the circulation and resident in tissue participate in inflammatory processes within and outside the kid ney [102] [103] [104] [105] [106] [107] . Thus, the presence of RAS components within leukocytes might enable the system to exert localized, targeted effects at sites of infection and/or inflamma tion without the need to increase plasma levels of renin, angio tensinogen or angiotensin peptides through clas sical endocrine pathways, which could result in detri mental circulatory changes such as hypertension. In this manner, aggregates of leukocytes would behave as small carriers of RAS components, which could act intracellularly or extracellularly at the site of infection without interfering with the endocrine functions of the RAS and/or affecting circulatory homeostasis 101, 103, 108, 109 . The potential role of a leukocyte RAS in disease processes, such as hypertension, inflammatory vascu lar disease and haematopoietic neoplasia, is supported by experimental and clinical data from the past few years [104] [105] [106] [107] 110 . For example, a 2017 study demonstrated that the expression of ACE enhances the defence capa bilities of neutrophils against bacterial infections such as methicillinresistant staphylococcus, probably by enhancing superoxide production 111 . Whether renin in lymphocytes is simply a marker of a special subtype of B lymphocytes or has a role unrelated to angiotensin generation remains to be determined. The fact that these primitive B renin cells retain phagocytic properties sug gests that they participate in innate immune responses. Further work is required to determine whether renin in B lymphocytes has a role independent of its traditional role in the regulation of blood pressure and fluidelectrolyte homeostasis. However, the possibility that a leukocyte RAS acts as a first line of defence against infec tions and other foreign antigens is an exciting prospect and an area for future exploration.
Changes in renin cell fate and disease
The RAS is a highly evolutionary conserved sys tem 24, 25, 112, 113 that has retained its main features through out evolution, enabling it to maintain volume and pressure homeostasis under pathophysiologic condi tions. The efficiency of reninexpressing cells to coun teract a threat to volume and pressure homeostasis can, under certain conditions, be detrimental. Mice, rats and humans with spontaneous or experimental mutations of any of the RAS genes can develop a spectrum of renal abnormalities including renal medullary underdevelop ment, hydronephrosis, an inability to concentrate urine, polyuria, polydipsia, renal failure and anaemia [114] [115] [116] [117] [118] [119] [120] [121] [122] . In addition, animals (including humans) with deletion of any component of the RAS develop characteristic renal arterial and arteriolar abnormalities that precede all other morphological and functional alterations 1, 5, 60, [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] . The arterioles under these circumstances are fewer and shorter than those of control animals, denoting a defect in vascular branching and elongation, and they display a characteristic concentric arteriolar hypertrophy (FIG. 8) . Similar vascular abnormalities have also been found in animals treated with RAS inhibitors in early life and in adult hypertensive rats treated with the RAS blockers aliskiren and valsartan 120, 126 , and several lines of evidence suggest that the primary site for the initiation of these abnormalities is the kidney vasculature. First, deletion of REN solely in the vasculature replicates the morpho logical and physiological abnormalities observed in global reninknockout mice, whereas deletion of REN in the tubular compartment does not cause any vascu lar alterations 127 . Furthermore, deletion of REN in the vasculature nearly eliminated plasma renin, indicating that vascular renin is the primary source of circulating renin and that the complex phenotype described above can be achieved by the vascular alterations induced by renin depletion in the vasculature 127 . Interestingly, ablation of reninexpressing cells with diphtheria toxin does not replicate the concentric vas cular hypertrophy of REN deletion, suggesting that the renin cells themselves are responsible for the vascular pathology 128 . To explore this hypothesis, we studied reninnull mice, which have the same phenotype as all the other models of RAS ablation and undetectable levels of angiotensin and renin, making it unlikely that the phenotype is caused by the enzyme or the angio tensin peptides themselves. Using genetic fate tracing and fluor escent reporting of renin promoter activity, we found that the cells that would normally express renin persist in the reninknockout mice and that these cells maintain the molecular memory of the renin phenotype, increase in number and are broadly distributed along the kidney vasculature (by contrast, reninexpressing cells are restricted to the a few juxtaglomerular cells in wildtype mice) 115 . Furthermore, these cells encircle the renal vessels and insert themselves in an apparently random fashion within the arteriolar walls among con centric layers of seemingly hyperplastic smooth muscle cells 115 (FIG. 8) . These findings suggest that renin cells contribute directly to the vessel pathology either by physical interaction and/or through the production of factors that induce the growth of smooth muscle cells. The identification of such factors might uncover poten tial therapeutic targets to prevent potential vascular complications that could occur during the treatment of hypertension. Although the mechanisms under lying this seemingly nonhomeostatic behaviour of renin cells are not understood, we hypothesize that although the evolutionary conserved ability of reninexpressing cells to sense and respond to sustained threats -such as hypotension and dehydration -by recruiting new reninproducing cells serves the organism well during early development, it can cause adverse outcomes when . Experimental or spontaneous mutations in genes of the renin-angiotensin system (such as genes that encode angiotensinogen, renin and angiotensinconverting enzyme, combined deletion of genes encoding angiotensin receptors 1A and 1B and deletion of aldosterone synthase (ALDOS; also known as CYP11B2)) leads to arteriolar abnormalities. This paraffin section from a renin-knockout mouse kidney immunostained for α-smooth muscle actin demonstrates short and thickened afferent arterioles (aa). The concentric vascular hypertrophy of an interlobular artery (IA) is caused by abnormal smooth muscle cells. Periglomerular (arrows) and interstitial (arrowheads) fibroses are also evident. G, glomerulus. Nature Reviews | Nephrology aa IA G G aa the desired homeostasis is not achieved. For instance, in mice with deletion of REN, the reninnull cells are con stantly stimulated by chronic hypotension and decreased volume. As they cannot produce renin, we suspect that the cells continue to attempt to restore homeostasis by activating a variety of genes that are part of the genetic programme of the renin phenotype, including expres sion of AKR1B7, miR330 and a variety of angiogenic and growth factors 39, 115 . This futile, chronic attempt to restore homeostasis enables the reninnull cells to main tain a fetallike state, resulting in the observed concen tric vascular hypertrophy. However, this hypothesis requires formal testing.
Other mutations that affect the phenotype of reninexpressing cells also markedly affect renin cell fate and kidney pathology. For example, conditional deletion of connexin 40 (CX40; also known as GJA5) in renin expressing cells results in the displacement of juxtaglo merular reninexpressing cells from the juxtaglomerular apparatus to areas surrounding the glomeruli 72 . As a result, the reninexpressing cells are unable to appropri ately sense perfusion pressure and are relatively insensi tive to ANGII. As a consequence, the CX40knockout mice develop severe hyperreninaemia and malignant hypertension 72, 129 . Conditional homozygous deletion of the histone acetyl transferases Cbp and p300 in mice results in an absence of reninexpressing cells and leads to endstage renal disease characterized by small kidneys possessing an irregular, granular and hard surface with cortical depressions that correspond histologically to bands of fibrosis replacing blood vessels. In addition, the mutant kidneys display cortical and medullary cysts 30 . The few reninexpressing cells present (less than 1-2% of num bers of wildtype mice) are thin and elongated, resem bling fibroblasts 30 . This study clearly demonstrates that these acetyl transferases are required for the maintenance of renin cells and the structural integrity of the kidney. The observed findings can be in part explained by the lack of renin cells but may also be due to the loss of CBP and/or p300 in cells that expressed renin early in develop ment because Cbp and p300 were deleted in all cells that expressed renin throughout development (such as renal arterioles, mesangial cells and tubular cells) 30 . Finally, deletion of the gene for the microRNA processing enzyme Dicer leads to a lack of crucial microRNAs and an absence of reninexpressing cells, resulting in the replacement of renal arterioles by bands of interstitial fibrosis resembling the 'striped' pattern of fibrosis typi cal of ciclosporin or tacrolimus toxicity 74 . In between the fibrotic bands of Dicerknockout mice are zones of fairly wellpreserved parenchyma. The larger intrarenal arter ies and arterioles are thickened by perivascular fibro plasia and not by an increase in the number of smooth muscle cells, suggesting that reninexpressing cells have either died or have not differentiated into smooth muscle cells. Careful fate tracing studies combined with markers of cell death are necessary to address these possibilities 74 .
In addition, the lack of reninexpressing cells in this model is associated with markedly decreased levels of plasma renin compared with those of wildtype animals and the development of hypotension. The combination of abnormal vessel architecture with hypotension leads to hypoperfusion and localized renal ischaemia, which further aggravates the fibrotic response 74 . These exam ples highlight the fundamental role of reninexpressing cells and their descendants in the development and main tenance of the structural and functional integrity of the kidney and in cardiovascular homeostasis and illustrate the consequences of their dysfunction.
Conclusions
Renin cell precursors appear early in the developing embryo and differentiate into multiple cell types in different tissues and organs. The descendants of early reninexpressing cells constitute a diverse group of cells with proposed roles in processes such as vascular morphogenesis during development and tissue repair. Available data suggest that these cells maintain a degree of plasticity and are able to switch phenotypes to con trol homeostatic processes such as blood pressure and volume balance as well as contribute to other defence processes involving cells of the haematopoietic and innate immune systems. Reninexpressing cells also have an intricate lineage and a functional relationship with EPOproducing cells and thus also have roles in tissue perfusion and in oxygen delivery to tissues.
Further work is needed to unravel the mechanisms that regulate renin cell identity, the plasticity of renin expressing cells and the functional diversity of these cells within different tissues. Such knowledge has the potential to facilitate the design of molecular-epigenetic approaches to target reninexpressing cells and the sys tems with which they interact to treat and/or prevent complications associated with the dysregulation of systems that are regulated by renin.
